{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sahpra-submissions-and-ec-approvals-coordination”
},
“@id”: “https://www.clinicalstudies.in/sahpra-submissions-and-ec-approvals-coordination”,
“headline”: “SOP for SAHPRA Submissions and EC Approvals Coordination”,
“name”: “SOP for SAHPRA Submissions and EC Approvals Coordination”,
“description”: “Comprehensive SOP for sponsors, investigators, and regulatory staff managing submissions to SAHPRA and coordinating with Ethics Committees (ECs) in South Africa, ensuring timely approvals and compliance.”,
“keywords”: “SAHPRA submission SOP, SAHPRA clinical trial approval, South Africa clinical trial SOP, SOP for SAHPRA EC coordination, SAHPRA ethics approval SOP, SOP for dual submission SAHPRA EC, SOP for investigator site submission South Africa, SOP for sponsor obligations SAHPRA, clinical trial governance South Africa SOP, SAHPRA clinical trial licensing, SOP for EC approval South Africa, SOP for protocol submission SAHPRA, SOP for site-specific assessment South Africa, SOP for investigator responsibility SAHPRA, SOP for trial lifecycle South Africa, SOP for inspection readiness SAHPRA, SOP for clinical trial coordination SAHPRA, SOP for site initiation South Africa, SOP for regulatory document submission SAHPRA, SOP for sponsor-SAHPRA interaction, SOP for EC queries South Africa, SOP for submission tracker SAHPRA, SOP for amendment submissions SAHPRA, SOP for sponsor compliance South Africa, SOP for TMF documentation SAHPRA”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

SAHPRA Submissions and EC Approvals Coordination SOP

Purpose

The purpose of this SOP is to define standardized procedures for preparing and submitting clinical trial applications to the South African Health Products Regulatory Authority (SAHPRA) and coordinating with local Ethics Committees (ECs). It ensures compliance with South African regulations, Good Clinical Practice (GCP), and international standards for ethical trial conduct.

Scope

This SOP applies to all clinical trials conducted in South Africa that require approval from SAHPRA and local ECs. It includes submission of Clinical Trial Applications (CTAs), essential documents, safety reports, amendments, and coordination of dual approvals prior to site initiation. It applies to sponsors, CROs, investigators, and regulatory affairs teams.

Responsibilities

• Sponsor: Prepares the CTA and ensures both SAHPRA and EC approvals are obtained before trial initiation.
• Regulatory Affairs (RA): Manages dossier preparation, submission, and communication with SAHPRA and ECs.
• Principal Investigator (PI): Provides site-specific documents and ensures site initiation only after approvals.
• Clinical Project Manager (CPM): Tracks timelines, monitors submissions, and records approvals in TMF.
• Quality Assurance (QA): Audits submission packages and ensures readiness for SAHPRA inspections.

Accountability

The Sponsor’s Head of Regulatory Affairs is accountable for ensuring submissions to SAHPRA and ECs meet requirements. The PI is accountable for ensuring trial conduct does not commence without both approvals.

Procedure

1. Preparation of Clinical Trial Application (CTA)

1. Compile CTA package including protocol, Investigator’s Brochure, informed consent forms, investigational product information, GMP certificates, and insurance certificates.
2. Ensure dossier follows SAHPRA’s guidance on electronic submission format.
3. Maintain CTA Preparation Checklist in TMF (Annexure-1).

2. Submission to SAHPRA

1. Submit CTA electronically through SAHPRA Clinical Trials portal.
2. Record acknowledgement reference number and submission date in Submission Log.
3. Respond to SAHPRA queries within stipulated timelines.

3. Ethics Committee (EC) Submissions

1. Prepare ethics submission package including protocol, informed consent forms, recruitment materials, and PI CVs.
2. Submit package to EC simultaneously with SAHPRA submission.
3. Document EC approval letters and file in TMF and ISF.

4. Coordination of Approvals

1. Ensure no site initiations occur until both SAHPRA and EC approvals are obtained.
2. Record final approvals in Approval Tracker (Annexure-2).

5. Amendments

1. Classify amendments as substantial or administrative.
2. Submit substantial amendments to both SAHPRA and EC before implementation.
3. Maintain Amendment Log (Annexure-3).

6. Safety Reporting

1. Submit SUSARs, DSURs, and safety notifications to SAHPRA and EC per timelines.
2. Ensure acknowledgment receipts are filed.

7. Archiving

1. Archive submission packages, approval letters, and correspondence for 15 years or as per SAHPRA requirements.

Abbreviations

• SAHPRA: South African Health Products Regulatory Authority
• EC: Ethics Committee
• CTA: Clinical Trial Application
• PI: Principal Investigator
• RA: Regulatory Affairs
• QA: Quality Assurance
• CPM: Clinical Project Manager
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. CTA Preparation Checklist (Annexure-1)
2. Approval Tracker (Annexure-2)
3. Amendment Log (Annexure-3)

References

• SAHPRA — Clinical Trials
• ICH E6(R2) Good Clinical Practice
• ICH Efficacy Guidelines

Version: 1.0

Approval

Annexures

Annexure-1: CTA Preparation Checklist

Annexure-2: Approval Tracker

Annexure-3: Amendment Log

Revision History

For more SOPs visit: Pharma SOP.